Harsha Rajasimha, PhD
As an entrepreneur, Dr. Rajasimha founded Jeeva Informatics Solutions (www.Jeevadx.com) in 2013, a life science BigData Informatics Company that received the ‘Bioscience Company of the Year 2014’ award from Montgomery County, MD. He founded the non-profit organization for rare diseases India (www.ordindia.org), serves as a board member and established mechanisms to raise awareness, accelerate rare disease diagnosis, policies and accessibility of treatments for patients in India. He has led strategic business development initiatives even while in technical and scientific roles for past employers.
An accomplished scientist, Dr. Rajasimha has authored over 15 peer-reviewed articles, book chapters, and is often invited speaker at international conferences. He has contributed to global standards initiatives such as BioPAX, DELSAGlobal, personalized medicine coalition, and the global alliance for genomics and health. He earned baccalaureate degree in computer science engineering from Bangalore University, Masters in Computer Science & Bioinformatics and Doctoral degree in interdisciplinary program genetics, bioinformatics and computational biology from Virginia Tech.
Dr. Harsha Rajasimha has over 15 years of experience and widely recognized in the field of systems biology, Genomics BigData analytics, rare diseases and precision medicine for cancer. Dr. Rajasimha is global vice president at Strand Life Sciences (www.strandls.com), a precision medicine company that develops genomics based clinical lab developed tests for Cancer and inherited diseases. He is affiliate faculty and co-director of the center for metabolic and rare diseases at George Mason University.
As a software engineer, Dr. Rajasimha led the development of some of the largest interdisciplinary BigData projects in Bioinformatics including PathogenPortal, Pathosystems resource integration center (funded by NIH), Cancer Biomedical Informatics Grid (caBIG funded by NCI), Cyberinfrastructure development for National Eye Institute's genomics program (funded by NEI), laboratory information management systems (STARLIMS) implementation at the FDA Office of Regulatory Affairs, and architected / directed the development of Genome Explorer®, an enterprise integrated platform for next-generation sequencing data analysis for Genome International Corporation. His contributions to the next-generation sequencing program at NEI were recognized by director’s innovation award in 2012.